Karin Fijnvandraat

Sanquin — Netherlands

Medicine · Health Sciences

50h-index8.4kcitations360works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemophilia Treatment and Research(164), Platelet Disorders and Treatments(142), Hemoglobinopathies and Related Disorders(84), Blood groups and transfusion(59), Blood Coagulation and Thrombosis Mechanisms(46)

Publications356 total

Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study
Journal of Thrombosis and Haemostasis·2025· 1 citedOpen Access
Correction: Rewriting the script: gene therapy and genome editing for von Willebrand Disease
Frontiers in Genome Editing·2025Open Access
Sickle cell disease in europe: A cross-border real-world data analysis from the radeep registry
Blood·2025Open Access
Data validation and quality framework for building a european multimodal real-world dataset for clinical outcome research in sickle cell disease
Blood·2025Open Access
Clinical outcomes up to 4 years of once-weekly efanesoctocog alfa prophylaxis in previously treated adults, adolescents, and children with severe hemophilia A: Interim analysis of the Phase 3 XTEND-ed long-term extension study
Blood·2025
Heterozygous nonsense FLI1 p.Met100∗ variant results in thrombocytopenia and increased erythroid gene expression
Research and Practice in Thrombosis and Haemostasis·2025Open Access
Large deletions in the F8 gene predict immune tolerance induction failure in people with severe hemophilia A
Research and Practice in Thrombosis and Haemostasis·2025Open Access
A qualitative study on the impact of hemophilia on sexual functioning and well-being in Dutch men
Journal of Patient-Reported Outcomes·2025Open Access
MHC class II presentation of FVIII-AnnexinA5 fusion proteins internalized by antigen presenting cells
Frontiers in Immunology·2025Open Access
Rewriting the script: gene therapy and genome editing for von Willebrand Disease
Frontiers in Genome Editing·2025· 2 citedOpen Access
Individualized Prediction of Platelet Transfusion Outcomes in Preterm Infants With Severe Thrombocytopenia
JAMA·2025· 3 citedOpen Access
A qualitative study on the impact of bleeding disorders on the daily life of Dutch women
Women s Health·2025· 1 citedOpen Access
F9 missense variant hot spots associated with qualitative protein defects causing hemophilia B
Blood Vessels Thrombosis & Hemostasis·2025Open Access
Chromogenic vs one-stage assay to diagnose women and girls with hemophilia A—mapping global approaches and assessing challenges: communication from the SSCs of the ISTH
Journal of Thrombosis and Haemostasis·2025
Clinical phenotype and pathophysiological mechanisms underlying qualitative low VWF
Blood·2025· 4 citedOpen Access
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype
HemaSphere·2025· 2 citedOpen Access
Plasma proteomics in patients with von Willebrand disease and hemophilia A highlights von Willebrand factor as main determinant of response to desmopressin treatment
Research and Practice in Thrombosis and Haemostasis·2025Open Access
Sexuality and bleeding in von Willebrand disease
Research and Practice in Thrombosis and Haemostasis·2025· 2 citedOpen Access
Long-term Outcomes With Efanesoctocog Alfa Prophylaxis for Previously Treated Children With Severe Hemophilia A, an Interim Analysis of the Phase 3 XTEND-ed Study
Hämostaseologie·2025
Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical research
Research and Practice in Thrombosis and Haemostasis·2025· 2 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

Marjolein Peters(19), Johanna G. van der Bom(19), Frank W.G. Leebeek(15), Marjon H. Cnossen(14), Karina Meijer(12), Britta A. P. Laros‐van Gorkom(11), Jeroen Eikenboom(10), Pieter W. Kamphuisen(7), Yvonne Sanders(7), Evelien P. Mauser‐Bunschoten(6), Marten R. Nijziel(6), Eveline P. Mauser‐Bunschoten(6), Corien L. Eckhardt(5), Martha A. Grootenhuis(5), Joke de Meris(5), Karly Hamulyák(4), Johannes Oldenburg(4), Frans J. Smiers(4), Jan Voorberg(4), Jan W. ten Cate(4)